Brucellosis

Alessandro Gerada

2023

Brief history of brucellosis

Described in many historical texts, all the way back to Hippocrates in 450 BC:

”Protracted fevers accompanied by ‘tumours’ and joint aches” (Hippocrates, n.d.)

In 1751, Cleghorn describes intermittent tertian fevers in Minorca (Cleghorn 1749).

In 1859, Assistant Surgeon Jeffrey Allen Marston described his own symptoms of “Mediterranean remittent” fever:

There is no fever so irregular as this in its course and symptoms


Sir David Bruce, in 1886, visualised and isolated Micrococcus melitensis from the spleen of a post-mortem patient:

“As it had been found by experiment that the air of the mortuary was peculiarly rich in germs … I removed the spleen to a small room in my quarters, the door and window of which had been keep shut for some time” (Bruce 1887)

Etymology

Other important historical milestones

Development of serum agglutination method by Wright in 1897

Isolation of M. melitensis from goats by Temi Zammit in 1905

Against all odds

Zammit’s first attempt at investigated serostatus of 7 goats (H. V. Wyatt 2005):

Repeated experiment in 1905 on 6 goats – 5 positive

Importantly, infected goats remained healthy

Mediterranean fever commission

(The Members of the Mediterranean Fever Commission. n.d.)


Sir Temi Zammit led the excavation of Tarxien temples (image c/o Heritage Malta)

Public health measures

Pasteurisation was not introduced until the late 1930

Public health measure to ban goat milk was put in place in 1906 (replaced with imported canned milk).

A milkman strike in protest of the measures likely contributed to disease control (Vassallo 1992).


(H. P. Wyatt 2013)

Bruce and the microbe

David found a little Germ

Its name, of course, you know;

For everywhere that David goes

That name is sure to go.

He found it in a Spleen one day,

And raised a cultured stock;

“With you,” he said “I’ll demonstrate

The postulates of Koch.. ”

David knew a little Boat

That was for New York bound,

With five-and-sixty little goats

That yielded milk all round.

And in the milk that microbe lurked.

(Hence David would forbid it),

And when the men got sick and ill,

“Twas germs,” he said, “that did it.”

(Vassallo 1992)

Bacteriology of Brucella spp

Brucella colonies

(Anantha et al. 2019)

Brucella Gram stain

(Anantha et al. 2019)

Pathogenesis and immunity

Intracellular survival protects organism:

Incomplete immunity

Species

In 2020, the Ochrobactrum genus was controversially assigned to the Brucella genus (Moreno et al. 2022)

Species Preferred zoonotic host
B. melitensis goats, camels
B. abortus cattle
B. suis pigs
B. canis dogs
B. ovis sheep
B. pinnipedialis sea mammals

Transmission and risk factors

Modality Mechanism
inhalation aerosols
ingestion dairy products
direct contact inoculation/hypersensitivity
uncommon human breast milk
sexual
blood transfusion
bone marrow transplant

Worldwide epidemiology

(Pappas et al. 2006)

European epidemiology

(European Centre for Disease Prevention and Control 2022)

Clinical features of brucellosis in humans

Travel history is undoubtedly the most important question

Fever is the most important finding – classically undulating (waves) or remittent (comes and goes), although rarely seen

Musculoskeletal symptoms – differentiate febrile myalgia from localised bone and joint involvement

History may be long

Most patients are not severely unwell (if so, suggests infective endocarditis)

Any organ can be involved

Undulant fever

(Hardy et al. 1930)

Diagnosis – culture

Culture is unequivocal evidence of infection (i.e., Brucellae do not colonise)

Blood culture:

Bone marrow has higher sensitivity – 60%

Other sites – joints, abscesses, etc.

Identification – MALDI-TOF is good, but defaults to B. melitensis

Laboratory risk

Significant laboratory risk – probably the most important laboratory pathogen (Traxler et al. 2013)

Largest laboratory outbreak reported in Lanzhou, China (2019) (Pappas 2022)

An inadequacy in sanitizing processes in a biopharmaceutical plant in Lanzhou, China, during July and August 2019, led to the aerosolization of Brucella that was subsequently spread through wind to nearby settlements and academic institutes, resulting in more than 10 000 human brucellosis cases…

…officials responsible for the leak have been identified and punished…

UK guidelines

Guidance on UK management available on BRU website (punishment for responsible microbiologists is not specified)

Castañeda medium

(Castaneda, n.d.)

Diagnosis – serology

Wright’s Serum Tube Agglutination remains the gold standard test – unchanged for over 120 years

Procedure:

B. canis lacks LPS, therefore needs specific serology

SAT

(Mariam et al. 2017)

Prozone effect

(Jin and Zehnder 2016)

Interpretation of serology tests

Variation between runs and interpreter – quality assurance is critical

Ideally demonstrate 4-fold increase in titre

An absolute cut-off is hard to define – certain titres may be tolerated in endemic areas

1:160 is the most agreed on cut-off

Other agglutination tests, e.g., Rose Bengal, work the same way

Diagnosis – PCR

Around 80% sensitive

Useful, but beware of idiosyncratic prolonged positivity

Treatment

Susceptibility testing is not helpful, although note that B. abortus live vaccine strain is inherently rifampicin resistant

Two agents minimum

Duration:

Antimicrobial agents

In order of likely efficacy:

Children (under 8) and pregnancy – rifampicin & co-trimoxazole

Global Impact

Brucellosis is likely to be the most common worldwide zoonotic disease

Although mortality rare, morbidity and loss of productivity due to illness is high

Brucella canis will continue to be of increasing concern in Europe and US

Lanzhou outbreak shows why Brucella spp continue to be recognised bioterrorism agents

Further reading

On laboratory acquired infection: Traxler, R.M., Lehman, M.W., Bosserman, E.A., Guerra, M.A., Smith, T.L., 2013. A literature review of laboratory-acquired brucellosis. J Clin Microbiol 51, 3055–3062. https://doi.org/10.1128/JCM.00135-13

On diagnostic methods: Yagupsky, P., Morata, P., Colmenero, J.D., 2019. Laboratory Diagnosis of Human Brucellosis. Clin Microbiol Rev 33, e00073-19. https://doi.org/10.1128/CMR.00073-19

On epidemiology and control: Corbel, M.J., Food and Agriculture Organization of the United Nations, World Health Organization, World Organisation for Animal Health, 2006. Brucellosis in humans and animals.

Others: Brucella Reference Unit website – flowcharts for laboratory exposure and request forms

CDC Brucella Reference Guide – useful general information

References

Anantha, Tejashree, Vidyavathii B. Chittaragi, M. Krishna Karthik, Jagadeesh Kumar, B. Suresh Kumar, and Badveti Satya Sai. 2019. “A Fatal, Rare Case of Bilateral, Upper, Lower Limbs and Abdominal Gangrene Associated with Brucellosis.” J Lab Physicians 11 (04): 388–90. https://doi.org/10.4103/JLP.JLP_46_19.
Bruce, David. 1887. “Note on the Discovery of a Micro-Organism in Malta Fever.” The Practitioner 39: 161–70.
Castaneda, M Ruiz. n.d. “A New Medium for the Isolation of Brucella and Salmonella by Blood Culture.”
Cleghorn, George. 1749. Observations on the Epidemical Diseases of Minorca: From the Year 1744 to 1749 : To Which Is Prefixed a Short Account of the Climate, Productions, Inhabitants, and Endemial Distempers of Minorca.
European Centre for Disease Prevention and Control. 2022. “Brucellosis - Annual Epidemiological Report for 2020.” Surveillance report. Stockholm.
Hardy, A V, C F Jordan, I H Borts, and Grace Campbell Hardy. 1930. “Undulant Fever With Special Reference to a Study of Brucelia Infection In Iowa,” October.
Hippocrates. n.d. On Epidemics.
Jin, Jing, and James L. Zehnder. 2016. “Prozone Effect in the Diagnosis of Lupus Anticoagulant for the Lupus Anticoagulant-Hypoprothrombinemia Syndrome.” Am J Clin Pathol 146 (2): 262–67. https://doi.org/10.1093/ajcp/aqw106.
Mariam, Abha, Masood Mir, Vivek Gupta, Omer Baba, Zahid Kashoo, Mudasir Rather, Hilal Khan, and Asif Sofi. 2017. “Prevalence of Brucellosis in Changra Goats of Cold Arid Desert, Ladakh, J and K.” Int. J. Livest. Res., 1. https://doi.org/10.5455/ijlr.20170129062556.
Moreno, Edgardo, José María Blasco, Jean Jacques Letesson, Jean Pierre Gorvel, and Ignacio Moriyón. 2022. “Pathogenicity and Its Implications in Taxonomy: The Brucella and Ochrobactrum Case.” Pathogens 11 (3): 377. https://doi.org/10.3390/pathogens11030377.
Pappas, Georgios. 2022. “The Lanzhou Brucella Leak: The Largest Laboratory Accident in the History of Infectious Diseases?” Clinical Infectious Diseases 75 (10): 1845–47. https://doi.org/10.1093/cid/ciac463.
Pappas, Georgios, Photini Papadimitriou, Nikolaos Akritidis, Leonidas Christou, and Epameinondas V Tsianos. 2006. “The New Global Map of Human Brucellosis.” The Lancet Infectious Diseases 6 (2): 91–99. https://doi.org/10.1016/S1473-3099(06)70382-6.
The Members of the Mediterranean Fever Commission. n.d. Accessed May 30, 2023. https://commons.wikimedia.org/wiki/File:The_members_of_the_Mediterranean_Fever_Commission._Wellcome_L0022610.jpg.
Traxler, Rita M., Mark W. Lehman, Elizabeth A. Bosserman, Marta A. Guerra, and Theresa L. Smith. 2013. “A Literature Review of Laboratory-Acquired Brucellosis.” J Clin Microbiol 51 (9): 3055–62. https://doi.org/10.1128/JCM.00135-13.
Vassallo, D. J. 1992. “The Corps Disease: Brucellosis and Its Historical Association with the Royal Army Medical Corps.” Journal of the Royal Army Medical Corps 138 (3): 140–50. https://doi.org/10.1136/jramc-138-03-09.
Wyatt, H V. 2005. “How Themistocles Zammit Found Malta Fever (Brucellosis) to Be Transmitted by the Milk of Goats” 98.
Wyatt, H. P. 2013. “Lessons from the History of Brucellosis: -EN- -FR- -ES-.” Rev. Sci. Tech. OIE 32 (1): 17–25. https://doi.org/10.20506/rst.32.1.2181.